MP16: Stone Disease: Epidemiology & Evaluation I

Poster Session Moderator(s)

• 

  Matthew Bultitude, MD

  Guy's and St. Thomas' Hospital, London
• 

  Thomas Chi, MD

  University of California San Francisco
• 

  Casey Dauw, MD

  University of Michigan

Presentations:

• 1:00 PM – 3:00 PM CST

  MP16-01: Machine Learning Model to Predict Likelihood of Spontaneous Ureteral Stone Passage
  

  Poster Presenter: Katherine M. Fischer, MD
• 1:00 PM – 3:00 PM CST

  MP16-02: Work Productivity of Patients Undergoing Trial of Passage for Ureteral Stones
  

  Poster Presenter: Ian Berger, MD, MS
• 1:00 PM – 3:00 PM CST

  MP16-03: The Impact of Timing of Definitive Intervention for Patients with Acute Renal Colic: A Population-Based Study
  

  Poster Presenter: Michael Ordon, MD, MSc, FRCSC
• 1:00 PM – 3:00 PM CST

  MP16-04: Effects of Delayed Surgical Intervention Following ED Presentation on Stone Surgery Complexity
  

  Poster Presenter: David Bayne, MD, MPH – UCSF Urology
• 1:00 PM – 3:00 PM CST

  MP16-05: A Novel EMR-based Care Pathway for Nephrolithiasis: Development and 1 Year Utilization
  

  Poster Presenter: Soum Datta Lokeshwar, MD, MBA (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP16-06: Machine learning-based decision support system to distinguish uric acid stones in patients with kidney stones of &[prime]grey zone&[prime] Hounsfield units: International multicenter development and external validation study
  

  Poster Presenter: Abdulghafour Halawani, MD, FEBU. (he/him/his) – University of British Columbia
• 1:00 PM – 3:00 PM CST

  MP16-07: A new predictor for calcium oxalate stones: Impact of linear calculus density on non-contrast computed tomography
  

  Poster Presenter: Dae Young Jun, MD (he/him/his) – Department of Urology, Severance Hospital
• 1:00 PM – 3:00 PM CST

  MP16-08: Distinguishing Characteristics of Children with Primary Hyperoxaluria Type 1 in PEDSnet
  

  Poster Presenter: Gregory E. Tasian, MD – Children's Hospital of Philadelphia
• 1:00 PM – 3:00 PM CST

  MP16-09: Vitamin C Therapy in Cancer Patients: Identifying Predictors of Stone Formation
  

  Poster Presenter: M. Reza Roshandel, MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP16-10: Effects of 24-hour Urinary Calcium Oxalate Supersaturation Levels on Stone Growth and New Stone Formation: When to Worry, When to Not?
  

  Poster Presenter: Antonio R. H. Gorgen
• 1:00 PM – 3:00 PM CST

  MP16-11: Carbonate Apatite Nephrolithiasis
  

  Poster Presenter: Nick S. Dean, MD – Northwestern Medicine
• 1:00 PM – 3:00 PM CST

  MP16-12: Kidney Stones and Osteoporosis: The Bone-Bowel-Kidney Axis
  

  Poster Presenter: Elizabeth P. Kwenda, MD – University of Florida College of Medicine
• 1:00 PM – 3:00 PM CST

  MP16-13: Cystinuria and Pregnancy: Clinical Course and Outcomes From 2000-2020
  

  Poster Presenter: Amy Reed, MD
• 1:00 PM – 3:00 PM CST

  MP16-14: Association of Frailty and Postoperative Outcomes of Percutaneous Nephrolithotomy
  

  Poster Presenter: Bruce Gao, MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP16-15: Disparities in inpatient care and outcomes for older adults with infected stones
  

  Poster Presenter: Alexandria Spellman, MD,MS (she/her/hers)
• 1:00 PM – 3:00 PM CST

  MP16-16: Postoperative Antibiotic Prophylaxis for Percutaneous Nephrolithotomy and Risk of Infection: a Systematic Review and Meta-Analysis
  

  Poster Presenter: Thalita Bento Talizin, MD,MSC
• 1:00 PM – 3:00 PM CST

  MP16-17: Prevalence of Kidney Stone Disease Among American Indian Adults in the Strong Heart Family Study
  

  Poster Presenter: Joseph J. Crivelli, MD – UAB Urology
• 1:00 PM – 3:00 PM CST

  MP16-18: Association Between Social Determinants of Health and 24-hour Urine Composition in Patients with Nephrolithiasis
  

  Poster Presenter: Max Abramson, BA (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP16-19: The Use of Genetic Testing for the Management of Nephrolithiasis : Knowns and Unknowns
  

  Poster Presenter: Sayi Pavankrishna Boddu, BA (he/him/his) – Mayo Clinic Arizona
• 1:00 PM – 3:00 PM CST

  MP16-20: Asymptomatic spontaneous stone passage is frequent in recurrent kidney stone formers: results of the prospective, randomized NOSTONE trial
  

  Poster Presenter: Kevin Stritt, MD (he/him/his) – Urology Department, CHUV